Antibody Jobs in Boston, MA

Fable Therapeutics - Boston, MA, United States

Associate Scientist - Antibody Discovery and Screening, Fable Therapeutics About Us: Fable Therapeutics (Fable) is a discovery-stage biotechnology company which develops purpose-built biologics

from: linkedin.com - 22 days ago

Astria Therapeutics, Inc. - Boston, MA, United States

our lead program, STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema, as well as STAR-0310, an OX40 monoclonal antibody

from: linkedin.com - 5 days ago

Boston, MA

of a Senior Technologist or when assigned. Demonstrates the ability to perform work in a manner that ensures accurate test results to include ABO, Rh, antibody screening, compatibility testing, direct

from: Pharmadiversityjobboard.com - 11 days ago

Fable Therapeutics - Boston, MA, United States

Associate Scientist -Antibody Discovery and Cell-based Assays, Fable Therapeutics About Us: Fable Therapeutics (Fable) is a discovery-stage biotechnology company which develops purpose-built

from: linkedin.com - 22 days ago

Fable Therapeutics - Boston, MA, United States

Senior Scientist - Antibody Discovery and Protein Interactions, Fable Therapeutics About Us: Fable Therapeutics (Fable) is a discovery-stage biotechnology company which develops purpose-built

from: linkedin.com - 22 days ago

Hillstar Bio - Boston, Massachusetts

is based in Boston’s Seaport neighborhood. Hillstar is advancing a portfolio of programs against autoimmune diseases with unmet or underserved medical needs. Its lead program is an antibody designed

from: resume-library.com (+1 source) - 17 days ago

X4 Life Sciences - Boston, MA, United States

Job Title: Director, Translational Sciences Company Overview: Join a dynamic and innovative clinical stage biotechnology company dedicated to developing novel antibody-based therapeutics for oncology

from: linkedin.com - 7 days ago

Astria Therapeutics, Inc. - Boston, MA, United States

our lead program, STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema, as well as STAR-0310, an OX40 monoclonal antibody

from: linkedin.com - 13 days ago

Merck - Boston, MA

antibodies and engineered proteins Close collaboration with Discovery and Early Development project teams in Boston (MA), South San Francisco (CA) and West Point (PA) aimed at building highly efficient

from: Pharmadiversityjobboard.com - 16 days ago

Bicara Therapeutics - Boston, MA, United States

modulators. The company’s bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting

from: linkedin.com - 16 days ago